Board suspends sale of certain anti-inflammatories

A prescribed drug was withdrawn from the Irish market today after three people died from liver failure.

Tue, 15 May, 2007 - 11:51

A prescribed drug was withdrawn from the Irish market today after three people died from liver failure.

Six other patients also needed liver transplants after taking nimesulide.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Dublin,Airport,Terminal,2.,Dublin,,Ireland.,March,2017 Dublin Airport runway maintenance 'will mean no sleep' for nearby residents due to diverted flights
Winner of 2018 Rose of Tralee would not enter competition now due to level of racist sentiment in society Winner of 2018 Rose of Tralee would not enter competition now due to level of racist sentiment in society
Mental research concentrated on wealthy, industrial nations, study finds  Mental research concentrated on wealthy, industrial nations, study finds 
CourtsHeathrowPlace: IrishPlace: UKPlace: IrelandPlace: DublinPlace: GalwayPerson: Darragh O’LoughlinOrganisation: Irish Medicines BoardOrganisation: IMBOrganisation: National Liver Transplant UnitOrganisation: Irish Dental AssociationOrganisation: IDAOrganisation: Irish Pharmaceutical UnionOrganisation: IPU
<p class="contextmenu Body Body">Research conducted by the Irish Fiscal Advisory Council earlier this year found that almost half of the corporation tax collected in 2024 came from just three companies, underlying the extent to which Ireland has come to rely on such income. File picture: Jim Dyson/Getty</p>

Corporation tax receipts increased by 500% in past 20 years, figures show 

READ NOW

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited